Possible interaction between imipramine and butalbital

Pharmacotherapy

Volumn 17, Issue 5 I, 1997, Pages 1041-1042

  Garey, Kevin W ^a   Amsden, Guy W ^a   Johns, Celeste A ^b  

^a BASSETT RESEARCH INSTITUTE   (United States)

^b Bassett Healthcare ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTALBITAL; CYTOCHROME P450; IMIPRAMINE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; HEADACHE; HUMAN;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BARBITURATES; DEPRESSIVE DISORDER; DRUG INTERACTIONS; FEMALE; HUMANS; IMIPRAMINE;

EID: 0030843952     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Moody JP, Whyte SF, MacDonald AJ, Naylor GJ. Pharmacokinetic aspects of protriptyline plasma levels. Eur J Clin Pharmacol 1977;11:51-6.
2. Alexanderson B, Evans DA, Sjoqvist F. Steady state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J 1969;4:764-8.
3. Silverman G, Braithwaite R. Interaction of benzodiazepines with tricyclic antidepressants. Br Med J 1972;4:111.
4. Burrows GD, Davies B. Antidepressants and barbiturates. Br Med J 1971;4:113.
5. Sallee FR, Pollock BG. Clinical pharmacokinetics of imipramine and desipramine. Clin Pharmacokinet 1990;18:346-64.
6. Abernethy DR, Greenblatt DJ, Shader RI. Imipraminecimetidine interaction: impairment of clearance and enhanced absolute bioavailability. J Pharmacol Exp Ther 1985;232:183-8.
7. Kroon C, de Boer A, Hoogkamer JFW, et al. Detection of drug interactions with single dose acenocoumarol: new screening methods? Int J Clin Pharmacol Ther Toxicol 1990;28:355-60.
8. Dossing M, Pilsgaard H, Rasmussen B, Poulsen HE. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism. Eur J Clin Pharmacol 1983;25: 215-22.